Drew Daniel Perkins

USPTO Granted Patents = 38 (Patent Applications = 1)

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 4.2

ph-index = 11

Forward Citations = 402(Granted Patents)

Location History:

Mansfield, TX (US) (2006)
Saratoga, CA (US) (2006 - 2023)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12303380 - Compensating corneal opacity (2025-05-20),

2. 12213874 - Restoring sight after corneal blindness (2025-02-04),

3. 12193928 - Intraocular femtoprojector (2025-01-14),

4. 11624938 - Unobtrusive eye mounted display (2023-04-11),

5. 11029535 - Unobtrusive eye mounted display (2021-06-08),

6. 10831269 - Brightness control for an augmented reality eye-mounted display (2020-11-10),

7. 10649233 - Unobtrusive eye mounted display (2020-05-12),

8. 10474230 - Brightness control for an augmented reality eye-mounted display (2019-11-12),

9. 9729946 - High-capacity switch (2017-08-08),

10. 9031412 - Coolerless photonic integrated circuits (PICs) for WDM transmission networks and PICs operable with a floating signal channel grid changing with temperature but with fixed channel spacing in the floating grid (2015-05-12),

11. 8660020 - Communication network with skew compensation (2014-02-25),

12. 8655169 - Degradation adaptation network (2014-02-18),

13. 8521020 - Forward error correction (FEC) enabled photonic integrated circuit (PIC) chips with multiple signal channels (2013-08-27),

14. 8442040 - Modular adaptation and configuration of a network node architecture (2013-05-14),

15. 8274892 - Universal digital framer architecture for transport of client signals of any client payload and format type (2012-09-25),

Title: The Innovative Journey of Drew Daniel Perkins

Introduction

Drew Daniel Perkins, hailing from Saratoga, California, has made significant strides in the field of medical technology, particularly in vision restoration. With an impressive portfolio of 36 patents, Perkins continues to push the boundaries of innovation, particularly through groundbreaking inventions aimed at enhancing eye health.

Latest Patents

Among his latest innovations is a remarkable electronic intraocular device designed to restore sight after corneal blindness. This device is implantable into the capsular bag of the wearer's eye, and it features a femtoprojector that projects images directly onto the retina. The intraocular device is designed with various haptic configurations to ensure optimal positioning of the femtoprojector. Additionally, some embodiments include an imager contained within a contact lens, which captures images to be relayed to the femtoprojector. This device also has the potential to improve eye health monitoring with an electronic capsular tension ring equipped with a femtoimager that captures images of the retina.

Career Highlights

Drew Perkins has had an influential career, contributing to the success of several prominent companies in the tech and medical sectors. Notably, he has worked with Infinera Corporation and Tectus Corporation. His work at these organizations has equipped him with the experience and knowledge that plays a crucial role in his innovative endeavors.

Collaborations

Throughout his career, Perkins has collaborated with talented individuals like David F Welch and Ting-Kuang Chiang. These partnerships have led to remarkable advancements in the field and a shared commitment to innovation and technology development.

Conclusion

Drew Daniel Perkins exemplifies a visionary inventor whose contributions significantly impact the realm of medical technology. His commitment to innovation is evident in his numerous patents and collaborations, promising a continued evolution in enhancing eye health for those in need. As technologies like his electronic intraocular device come to fruition, the potential for restoring sight is becoming a reality, reflecting the transformative power of ingenuity.

This text is generated by artificial intelligence and may not be accurate.